Kaye SB - Search Results

1

Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies.

Schellens JH, Heinrich B, Lehnert M, Gore ME, Kaye SB, Dombernowsky P, Paridaens R, van Oosterom AT, Verweij J, Loos WJ, Calvert H, Pavlidis N, Cortes-Funes H, Wanders J, Roelvink M, Sessa C, Selinger K, Wissel PS, Gamucci T, Hanauske AR. Schellens JH, et al. Among authors: kaye sb. Invest New Drugs. 2002 Feb;20(1):83-93. doi: 10.1023/a:1014454821885. Invest New Drugs. 2002. PMID: 12003197 Clinical Trial.

2

Activity and toxicity of GI147211 in breast, colorectal and non-small-cell lung cancer patients: an EORTC-ECSG phase II clinical study.

Gamucci T, Paridaens R, Heinrich B, Schellens JH, Pavlidis N, Verweij J, Sessa C, Kaye S, Roelvink M, Wanders J, Hanauske A. Gamucci T, et al. Ann Oncol. 2000 Jul;11(7):793-7. doi: 10.1023/a:1008373031714. Ann Oncol. 2000. PMID: 10997805 Free article. Clinical Trial.

3

Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours.

de Jonge MJ, Kaye S, Verweij J, Brock C, Reade S, Scurr M, van Doorn L, Verheij C, Loos W, Brindley C, Mistry P, Cooper M, Judson I. de Jonge MJ, et al. Br J Cancer. 2004 Oct 18;91(8):1459-65. doi: 10.1038/sj.bjc.6602178. Br J Cancer. 2004. PMID: 15452551 Free PMC article. Clinical Trial.

4

Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion.

Stevenson JP, DeMaria D, Sludden J, Kaye SB, Paz-Ares L, Grochow LB, McDonald A, Selinger K, Wissel P, O'Dwyer PJ, Twelves C. Stevenson JP, et al. Among authors: kaye sb. Ann Oncol. 1999 Mar;10(3):339-44. doi: 10.1023/a:1008313011289. Ann Oncol. 1999. PMID: 10355580 Free article. Clinical Trial.

5

A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion.

Paz-Ares L, Kunka R, DeMaria D, Cassidy J, Alden M, Beranek P, Kaye S, Littlefield D, Reilly D, Depee S, Wissel P, Twelves C, O'Dwyer P. Paz-Ares L, et al. Br J Cancer. 1998 Nov;78(10):1329-36. doi: 10.1038/bjc.1998.679. Br J Cancer. 1998. PMID: 9823974 Free PMC article. Clinical Trial.

6

Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group.

Verweij J, Wanders J, Nielsen AL, Pavlidis N, Calabresi F, ten Bokkel Huinink W, Bruntsch U, Piccart M, Franklin H, Kaye SB. Verweij J, et al. Among authors: kaye sb. Ann Oncol. 1994 Apr;5(4):375-6. doi: 10.1093/oxfordjournals.annonc.a058847. Ann Oncol. 1994. PMID: 8075039 Free article. Clinical Trial.

7

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.

Sulkes A, Smyth J, Sessa C, Dirix LY, Vermorken JB, Kaye S, Wanders J, Franklin H, LeBail N, Verweij J. Sulkes A, et al. Br J Cancer. 1994 Aug;70(2):380-3. doi: 10.1038/bjc.1994.310. Br J Cancer. 1994. PMID: 7914428 Free PMC article. Clinical Trial.

8

Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC.

Smyth JF, Smith IE, Sessa C, Schoffski P, Wanders J, Franklin H, Kaye SB. Smyth JF, et al. Among authors: kaye sb. Eur J Cancer. 1994;30A(8):1058-60. doi: 10.1016/0959-8049(94)90455-3. Eur J Cancer. 1994. PMID: 7654428 Clinical Trial.

9

Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.

Hanauske AR, Catimel G, Aamdal S, ten Bokkel Huinink W, Paridaens R, Pavlidis N, Kaye SB, te Velde A, Wanders J, Verweij J. Hanauske AR, et al. Among authors: kaye sb. Br J Cancer. 1996 Feb;73(3):397-9. doi: 10.1038/bjc.1996.68. Br J Cancer. 1996. PMID: 8562349 Free PMC article. Clinical Trial.

10

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

Bruno R, Hille D, Riva A, Vivier N, ten Bokkel Huinnink WW, van Oosterom AT, Kaye SB, Verweij J, Fossella FV, Valero V, Rigas JR, Seidman AD, Chevallier B, Fumoleau P, Burris HA, Ravdin PM, Sheiner LB. Bruno R, et al. Among authors: kaye sb. J Clin Oncol. 1998 Jan;16(1):187-96. doi: 10.1200/JCO.1998.16.1.187. J Clin Oncol. 1998. PMID: 9440742 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

738 results

Search Page

Filters